Inmolecule Nanotech (XPAR:MLINA) Total Operating Expense: €1.80 Mil (TTM As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Total Operating Expense?

Inmolecule Nanotech XPAR:MLINA 6 Total Operating Expense is €1.80 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Total Operating Expense for the six months ended in Dec. 2024 was €1.80 Mil. Inmolecule Nanotech's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €1.80 Mil.

Inmolecule Nanotech Total Operating Expense Related Terms

Inmolecule Nanotech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Total Operating Expense Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Total Operating Expense
2.46 1.80

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Total Operating Expense 2.46 1.80
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €1.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €1.80 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Total Operating Expense of €1.80 Mil as of Dec. 2024. Total operating expense is the primary recurring expense associated with central operations. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Total Operating Expense too high?
Inmolecule Nanotech's current Total Operating Expense is €1.80 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Total Operating Expense compare to VRTX and REGN?
Inmolecule Nanotech's Total Operating Expense of €1.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Total Operating Expense is €1.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Total Operating Expense of €1.80 Mil. The current Total Operating Expense is €1.80 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Total Operating Expense is €1.80 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price